ArticleMolecular therapy. Nucleic acids2021

Overexpression of BIRC6 driven by EGF-JNK-HECTD1 signaling is a potential therapeutic target for triple-negative breast cancer.

Yongpeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.